Recently, we found epigenetic silencing of the Ras effector genes NORE1B and/or RASSF1A in 97% of the hepatocellular carcinoma (HCC) investigated. This is strong evidence that the two genes are of major significance in hepatocarcinogenesis. Although RASSF1A serves as a tumor suppressor gene, the functions of NORE1B are largely unknown. Here, we studied the role of NORE1B for growth and transformation of cells. To understand the molecular mechanisms of action of the gene, we used the wild-type form and deletion mutants without the NH 2 terminus and CENTRAL domain, the Ras association (RA) domain, or the COOH-terminal SARAH-domain. Intact RA and SARAH-domains were found to be necessary for NORE1B (a) to increase the G 0 -G 1 fraction in hepatoma cells, (b) to suppress c-Myc/Ha-Ras-induced cell transformation, and (c) to interact closely with RASSF1A, as determined with fluorescence resonance energy transfer. In further studies, cell cycle delay by NORE1B was equally effective in hepatocyte cell lines with wild-type or mutant Ras suggesting that NORE1B does not interact with either Ras. In conclusion, NORE1B suppresses replication and transformation of cells as effectively as RASSF1A and thus is a putative tumor suppressor gene. NORE1B interacts physically with RASSF1A and functional loss of one of the interacting partners may lead to uncontrolled growth and transformation of hepatocytes. This may explain the frequent epigenetic silencing of NORE1B and/or RASSF1A in HCC.
Introduction
Hepatocellular carcinoma (HCC) is among the most frequent types of cancer worldwide accounting for approximately half a million deaths per year (1) . The molecular mechanisms underlying the development of this disease are not well-understood (2, 3) . In sharp contrast to other types of human malignancies, activating mutations in one of the Ras genes occur rarely in HCC (3) (4) (5) . We recently found epigenetic inactivation of the Ras effector genes NORE1B and RASSF1A in the majority of HCC due to CpG-site hypermethylation in the promoter regions. As a result, 97% of the 28 tumors studied revealed epigenetic inactivation of NORE1B, RASSF1A, or both (6) . However, the Ras effector NORE1A was not affected by hypermethylation. This raised our interest in the significance of NORE1B and RASSF1A for the development of liver cancer.
Ras effectors are defined as proteins with strong affinity to GTPcharged forms of Ras, Rap-1, and several other Ras subfamily GTPases (5) . Currently, there are >10 different Ras effectors, such as RAF, RalGDS, phosphatidylinositol 3-kinase, and the RASSF gene family comprising RASSF1 and NORE1 (RASSF5; refs. 5, 7-11). The interaction of these effectors with GTP-charged Ras may trigger various signaling cascades, which induce not only growth, survival, and migration of cells but also cell cycle arrest, differentiation, senescence, and apoptosis (5, (7) (8) (9) (10) . These diverse biological effects may serve for the fine tuning of the cellular homeostasis. However, details in the interplay between the various Ras effector-mediated pathways and the biological consequences are still unknown.
Members of the RASSF family are deleted or repressed selectively by gene loss and/or epigenetic mechanisms in a considerable fraction of epithelial cancers and cell lines derived thereof. Reexpression usually suppresses the proliferation and tumorigenicity of these cells (7, (8) (9) (10) (11) (12) (13) (14) . Accordingly, RASSF1A knockout mice show enhanced tumor susceptibility, and loss of function of the NORE1 gene is linked to a familial form of kidney cancer (15, 16) . Thus, RASSF proteins act as tumor suppressors, which contrasts to the oncogenic effects of most other Ras effectors known, such as Raf or PI3-K.
The predominant RASSF family members are all characterized by the presence of a Ras association domain (RA) of the RalGDS/ AF6 type (7) (8) (9) (10) . As a result of alternative splicing and/or differential promoter usage RASSF1 codes for RASSF1A and six further isoforms (RASSF1B-G), whereas NORE1 gives rise to NORE1A and NORE1B (also called RAPL). RASSF1A, NORE1A, and NORE1B all contain a COOH-terminal SARAH-domain, which may mediate interactions with bax-activating protein kinases (9, (17) (18) (19) . NORE1B harbors a RA-domain like NORE1A, but binding to GTP-charged Ras proteins has never been proven. Because NORE1B transcription starts from an alternative exon 2h, located f48 kb downstream of exon 1, the product lacks the NH 2 -terminal diacylglycerol-binding domain (DAG), the presumed linking site for RASSF1A. RASSF1A associates not directly with Ras-like GTPases but heterodimerizes with NORE1A, serving as link to GTP-charged Ras (9, 20, 21) . Thus, the actual binding partners and functions of NORE1B have not been identified.
To understand the significance of the frequent NORE1B silencing in hepatocarcinogenesis, we studied the wild-type gene and several deletion mutants lacking the known functional domains. The results show that NORE1B antagonized cell transformation and delayed the cell cycle as effectively as the tumor suppressor RASSF1A. These effects require the RA and SARAH-domain, which serve to interact with RASSF1A and not with GTP-charged Ras. In conclusion, our data indicate a close cooperation of NORE1B and RASSF1A in the maintenance of cell homeostasis. Thus, the functional loss of NORE1B and/or RASSF1A, as observed in almost all HCCs, may contribute significantly to uncontrolled growth and transformation of hepatocytes.
Materials and Methods
Plasmids and constructs. Human NORE1B, NORE1A, RASSF1A, pECFPtagged Ha-Ras-wt, and pECFP-tagged Ha-Ras-G12V were kind gifts from J. Avruch (Massachusetts General Hospital, Boston, MA), A. Khokhlatchev (University of Virginia, Charlottesville, VA) R. Dammann (University of Halle, Germany), and A. Wittinghofer (Max-Planck Institute, Düsseldorf, Germany), respectively. NORE1B -deletion mutants lacking the NH 2 terminus or the SARAH-domain were generated by PCR, deletants without RA-domain by site-directed mutagenesis, as described (22) . For a list of primers and PCR conditions, see Supplementary Data. The coding regions of NORE1Bwt, deletion mutants, RASSF1Awt , and NORE1Awt , were sequenced and subcloned in-frame into pEYFP or pECFP.
Cell-lines. The human hepatocarcinoma cell-line Hep3B (ATCC-No HB-8064) was maintained as described (6) . The absence of mutations in exons 2 and 3 of N-, Ha-, and Ki-Ras was verified by sequencing. Primer sequences are given in the Supplementary Data and methodical details in a study by Macheiner and colleagues (6) . MIM-1-4 immortalized murine hepatocytes, deriving from p19ARFÀ/À mice, and MIM-R hepatocytes, established from p19ARFÀ/À and transformed with oncogenic v-Ha-Ras, were generated and cultured as given elsewhere (23) . Cells were retrovirally transduced with pMSCV-GFP (ClonTech) and in a second round with pBabepuro harboring NORE1Bwt, NORE1Awt , or RASSF1Awt. Cells were kept in 5 Ag of puromycin/mL medium for f2 wk and resistant clones were isolated and propagated.
Reverse transcription-PCR. Total RNA was extracted, reversely transcribed applying random primers and Moloney murine leukemia virus reverse transcriptase, and PCR products were analyzed by electrophoretic separation, as described (6) .
siRNA. Silencer Select siRNAs targeting human NORE1B with the sequences 5 ¶-CACUGCUAAGACUACCUUUTT-3 ¶ and 5 ¶-AAAGGUAGU-CUUAGCAGUGAA-3 ¶ were custom-made by Ambion (''siNORE1B''). A nonsilencing Silencer Select scrambled siRNA (''siSCRAMB, '' No AM4390843; Ambion) and Cy3-labeled Silencer glyceraldehyde-3-phosphate dehydrogenase (GAPDH; ''siGAPDH, '' No AM4649; Ambion) were used as controls. Cells were transfected with either 30 nmol/L (siSCRAMB and siNORE1B) or 10 nmol/L (siGAPDH) siRNAs using siLentFect (BioRad) according to the manufacturer's instructions and were incubated for 24 h until analyses. TaqMan-based ''gene expression assays'' for h2-microglobulin, GAPDH, and NORE1B (ABI) were applied on an ABI-Prism/7500 Sequence Detection System (ABI). Changes in expression levels were determined using h2-microglobulin as house-keeping gene according to previous descriptions (6) . All data were analyzed in duplicates. For further details, see Fig. 1 .
Immunoblotting. Cells were centrifugated for 5 min at 800 Â g at 20jC. The pellet was washed with PBS and cells were suspended in lysis buffer. Lysates were incubated on ice for 30 min, sonicated, and centrifugated for 5 min at 13.000 Â g at 4jC. Protein samples (25 Ag per lane) were separated by SDS-PAGE (12%) and electroblotted to Hybond-P membranes (Amersham Bioscience). Immobilized proteins were detected using antisera, as listed in the Supplementary Data. The staining signal was detected by enhanced chemiluminescence (Amersham Bioscience) on Kodak-X-Omat sheets (Kodak). Due to high homology, anti-NORE detected NORE1A and NORE1B of human and rodent origin.
Confocal laser scanning microscopy. Hep3B-cells were transfected with 1 Ag of pEYFP-or pECFP-tagged constructs or with 0.5 Ag of each plasmid DNA in case of double-transfections applying Fugene 6 (Roche Applied Bioscience); 24 h later, cells were fixed with formalin for 30 min, and the DNA was stained with Hoechst 33258 (0.8 Ag/mL in PBS). Images were obtained by a LSM510 Meta-confocal microscope (Carl Zeiss).
Fluorescence resonance energy transfer. Cells were transfected as described above. After 24 h, images were obtained with a Nikon Eclipse TE300 microscope (Nikon), equipped with a SenSys camera, and applying a CFP (donor)-, a YFP (acceptor)-, and a RAW-fluorescence resonance energy transfer (FRET; acceptor emission at donor excitation)-filter. The FRET signals were calculated with MetaMorph 5.0 software as an intensitymodulated display image (24) . After determination of the correction factor for CFP and YFP, FRET was calculated using the formula: CO, not transfected; YFP, transfected with pEYFP only. B and C, Hep3B-cells were transiently transfected with siRNAs targeting NORE1Bwt (siNORE1B ), GAPDH (siGAPDH ), and scrambled siRNA (siSCRAMB) or were exposed to the transfection reagent only (CO ). The effect of siRNAs on the NORE1B expression level was determined by quantitative reverse transcription-PCR and on the cell cycle by FACS analyses. C, relative alterations in the cell cycle distribution are calculated for siNORE1B versus untransfected and for siNORE1B versus siGAPDH. A to C, experiments were done in triplicate; columns, mean; bars, SE. Statistical analyses were performed with the Kruskal-Wallis test in (A) for YFP-tagged control vector versus other constructs and in (C ) for siNORE1B versus untransfected and siNORE1B versus siGAPDH separately for each phase of the cell cycle: G 0 -G 1 phase, (a) P < 0.05; S phase, (b ) P < 0.05;Cell transformation and cloning efficiency. Primary rat embryo cells (REC) were isolated at day 15.5 of gestation by fractionated trypsinization and cultivated as described in detail (26); 24 h after plating cells were transfected via the calcium phosphate technique applying 20 Ag of DNA containing 6 Ag of pVEJ.B (encoding Ha-Ras), 6 Ag of pSPmyc (encoding c-Myc), 8 Ag of pBabepuro containing either NORE1Bwt, NORE1B deletion mutants, RASSF1Awt, NORE1Awt, or pBabepuro only. About 72 h later, cells were switched to a medium containing 5% FCS. After f10 d, the dishes were stained with Giemsa and the number of cell colonies was counted.
To test for cloning efficiency, RECs were transfected as described above and were selected with geneticin (200 Ag/mL; Invitrogen) After 9 d, clones were isolated and maintained in selection medium.
Cell cycle analysis. Cells were fixed in 3% paraformaldehyd, RNA was digested with RNase A (10 mg/mL; Qiagen), and DNA was stained with propidium iodide (2.5 Ag/mL; Sigma). Analyses were performed with a FACS Calibur Flow Cytometer (Becton Dickinson).
Statistics. Where indicated, statistical analysis were performed by the nonparametric Krukal-Wallis test. All tests were calculated as two-tailed.
Results
Human NORE1B encodes a 265 amino acid (aa) protein, which consists of a unique 40 residue NH 2 terminus, followed by the CENTRAL-domain (aa 41-115), RA-domain (aa 116-207), and COOH-terminal SARAH-domain (aa 208-265; refs. 7, 9). To understand the functions of these domains we generated the following deletants: NORE1B_Nterm lacking aa 1-107, NORE1B_RA lacking aa 113-226, and NORE1B_SARAH without aa 222-265. For further information, see Supplementary Data. The effects of the wild-type form and the deletion mutants on growth, transformation, and on subcellular localization were studied.
NORE1B delays proliferation of hepatoma and hepatocyte lines. By fluorescence-activated cell sorting (FACS) analyses, we first checked the effect of NORE1B, NORE1A, and RASSF1A on the cell cycle of the human hepatoma cells Hep3B, a line with inherently low endogenous expression of these genes (6) . The transfection stressed the cells as indicated by absence of the G 2 -M phase. Expression of NORE1Bwt induced an increase of cells in G 0 -G 1 by 32%. This effect was somewhat less pronounced for NORE1B_Nterm and NORE1B_RA, and was absent when transfecting NORE1B_SARAH (Fig. 1A) . NORE1Awt and RASSF1Awt also elevated the G 0 -G 1 fraction of Hep3B-cells. On the other hand, knockdown of NORE1B reduced the percentage of cells in G 0 -G 1 by f12% and elevated the S-and G 2 -M fraction together by f40% (Fig. 1B and C) . This was first evidence that NORE1B may delay the cell cycle, as known for RASSF1A and NORE1A, and that mainly the SARAH-domain is of importance for this effect (27) (28) (29) (30) (31) (32) (33) .
To obtain stable expressions close to physiologic levels, we inserted NORE1Bwt, NORE1Awt, and RASSF1Awt retrovirally into murine hepatocyte lines without (MIM-1-4) and with mutant Ha-Ras (MIM-R). In all sublines generated, the inserts were transcribed ( Fig. 2A) , whereas proteins remained below the detection level (data not shown). The vector alone had nearly no effect on the growth of the cells (Fig. 2B) . However, replication was significantly reduced in MIM-1-4 and MIM-R cells expressing NORE1B, NORE1A, or RASSF1A as manifested by significantly decreased cell numbers after a cultivation period of 3 days. When Figure 2 . Effects of NORE1B, NORE1A, and RASSF1A on growth and cell cycle of hepatocyte lines. Retroviruses coding for NORE1Bwt, NORE1Awt , or RASSF1Awt were inserted into MIM-1 and MIM-R hepatocyte lines. A, expression of the constructs was verified by RT-PCR; h-actin was used as control for mRNA integrity and equal loading. Due to high homology between murine and human NORE1A, primers detected endogeneous NORE1A. B, cells were seeded at 4 Â 10 5 per plate. Subconfluent cultures were harvested after 72 h and cells were counted. C, cell cycle distribution of asynchronous cultures was determined by FACS analyses. D, assuming logarithmic growth, cell counts of B served to determine the population doubling time, which is identical to the mean duration of the cell cycle. The relative cell cycle distribution, determined in C , reflects the relative duration of each phase per cycle. Based on the data generated in B and C , the mean duration of G 0 -G 1 , S, and G 2 -M phase was calculated. Experiments were done in triplicate. Co, untreated MIM-R or MIM-1-4 cells; pBabe, transfected with vector only. Columns, mean; bars, SE (C-D). Statistical analyses were performed by the Kruskal-Wallis test for control vector (pBabe) versus other constructs. *, P < 0.05 (B ). C and D, significance of data was tested for each phase of the cell cycle separately: G 0 /G 1 phase, (a) P < 0.05; S phase, (b) P < 0.05; G 2 -M phase; (c ) P < 0.05. (Fig. 2D) . A similar effect was observed with NORE1A and RASSF1A.
NORE1B antagonizes cell transformation. RECs were transfected with plasmids encoding for c-Myc/Ha-Ras, which produced numerous transformed cell clones (Fig. 3) . Cotransfection with NORE1Bwt or NORE1B_Nterm significantly lowered focus formation by 24%. NORE1B_RA and NORE1B_SARAH exerted no decrease indicating that the RA-and SARAH-domain may be important for interference with c-Myc/Ha-Ras induced cell transformation. The number of foci was not significantly affected by RASSF1Awt or NORE1Awt. However, the combination of RASSF1Awt and NORE1Bwt was even more effective than NORE1Bwt alone and suppressed focus formation by f50% (Fig. 3) . This indicates that NORE1B with an intact RA-and SARAH-domain lowers cell transformation and that this effect becomes even more evident in the presence of RASSF1A.
We isolated six clones per group, all of which expressed the ectopic constructs at mRNA and protein levels (Fig. 4) . Unlike the control clones with a fibroblastoid morphology and 0.4 cell doublings per day, NORE1Bwt-clones showed an epitheloid morphology (Fig. 3B) and a somewhat reduced population doubling time of 0.3 per day (Fig. 4) . RASSF1Awt, however, did not alter morphology (data not shown) but significantly reduced the population doublings when compared with control-and NORE1Bwt-clones. We conclude that NORE1B impairs the development and growth of c-Myc/Ha-ras transformed cells and changes the morphology of the transformed clones.
Subcellular localization of NORE1B, NORE1A, and RASSF1A. In Hep3B cells, YFP-tagged NORE1Bwt was localized in the cytoplasm and excluded the nucleus (Fig. 5 ). RASSF1Awt impressed with a meshwork-like pattern in the cytoplasm (Fig. 5) . Dot-like structures close to the nucleus were formed by NORE1Awt (Fig. 5) . The subcellular distribution of NORE1B_Nterm was still cytoplasmic, whereas NORE1B_RA was localized punctiform around and in the nucleus and NORE1B_SARAH predominantly nuclear. NORE1B harbors a nuclear export signal (NES) in the RA-domain close to the SARAH-domain. When blocking the nuclear export by leptomycin B (34), NORE1Bwt was localized predominantly in the nucleus (Fig. 5) . Thus, the lack of cytoplasmic occurrence of the NORE1B_RA or NORE1B_SARAH was probably due to lack or steric hindrance of the NES, respectively. The unaltered cytoplasmic location of NORE1B_Nterm under leptomycin B-treatment may be due to the deletion of a hitherto unidentified nuclear localization signal close to the NH 2 terminus. These data indicate that NORE1B may be active in the cytoplasmic and nuclear compartment of the cell.
NORE1B interacts with RASSF1A but not with wild-type or mutant Ha-Ras. To elucidate the molecular target of NORE1B, we double-transfected Hep3B cells. The presence of RASSF1Awt altered the subcellular localization of NORE1Bwt and NORE1B_ Nterm to a RASSF1A-like pattern but had no effect on the other NORE1B-deletants (Fig. 6A) . As a result, NORE1Bwt or NORE1B_Nterm distributed differently when compared with single transfections and exhibited colocalization with RASSF1A. To check for interactions between the two molecules, we performed FRET analyses (Fig. 6B) . The cotransfection of RASSF1A and NORE1A, a known RASSF1A-binding partner, produced a significant FRET signal. Transfecting RASSF1A with either NORE1Bwt or NORE1B_Nterm also resulted in considerable signals, whereas the combinations of NORE1Bwt/NORE1Awt, NORE1B_RA/RASSF1A, and NORE1B_SARAH/RASSF1A were ineffective (Fig. 6 ). This strongly suggests that NORE1B interacts physically with RASSF1A, which involves the RA-and the SARAH-domain.
NORE1A has been described to bind GTP-charged Ras proteins by its RA-domain (20) . Accordingly, in double-transfected Hep3B-cells NORE1A altered the subcellular distribution and colocalized with mutant Ha-Ras only and not with the wild-type form (Fig. 6C) . The absence of the FRET signal does not exclude interaction of NORE1A and mutated Ras because the energy transfer requires parallel orientation of donor and acceptor dipoles of the two fluorophores (35) . These preconditions are often not met by the labels of the transfectants. When cotransfecting NORE1Bwt with either wild-type or mutant Ha-Ras, NORE1B neither changed its subcellular localization nor did it produce a significant FRET signal (Fig. 6D) . Thus, a physical interaction of NORE1B with Ras in its wild-type or mutated form seems unlikely.
Discussion
In the majority of HCCs investigated, NORE1B was found to be epigenetically silenced (6) . The present report provides several lines of evidence supporting that NORE1B is a putative tumor suppressor gene and cooperates closely with RASSF1A, as outlined in the following. NORE1B, RASSF1A, and cell cycle. In hepatocyte and hepatoma cell lines, NORE1B, NORE1A, and RASSF1A increased the percentage of cells in G 0 -G 1 at the expense of the S-phase fraction. Retroviral insertion of NORE1B and RASSF1A in hepatocyte lines tended to increase additionally the G 2 -M fraction. As a result, cell cycle progression was significantly delayed and growth of the lines suppressed. Identical effects were reported for RASSF1A and NORE1A in cells derived from melanoma, kidney, cervix, breast, lung, and prostate cancer (27-30, 32, 36) . Data on hepatocytes or hepatoma cells have not been available. The molecular mechanisms of the G 1 -S and G 2 -M arrest by RASSF1A are largely identified. The protein complexes with the transcription factor p120 E4F , thereby delaying the G 1 -S transition via interference with p14ARF, retinoblastoma, p53, and cyclin A (9, 10, 27, 31) . During the interphase RASSF1A localizes to microtubules and is found in centrosomes and spindles during mitosis by binding to RABP1 (also called C19ORF5; ref. 37) . Overexpression of RASSF1A causes a prometaphase arrest by preventing activation of the anaphase-promoting complex/cyclosome, whereas depletion of RASSF1A accelerates mitotic progression and causes mitotic defects (9, 10, 29, 33) . Details of the molecular mechanisms underlying the reduced S-phase fraction by NORE1B, as observed in the present study, have yet to be defined. According to our data, the SARAH-domain and to some extent also the RA-domain of NORE1B are essential for growth suppression.
NORE1B and cell transformation. Under our experimental conditions, NORE1B antagonized c-Myc/Ha-Ras-induced transformation of embryonal cells. Only NORE1B constructs harboring the RA-/SARAH-domains and being capable of binding to RASSF1A, were effective. Interestingly, RASSF1A alone did not significantly antagonize cell transformation but enhanced greatly the NORE1B effect, which indicates cooperation of these genes. In the clones generated, the effects of NORE1B and RASSF1A seemed to persist as being evident by a reduced population doubling time over an observation period of several weeks.
Previous studies described a colony-suppressing activity of NORE1B, NORE1A, and RASSF1A in cancer cell lines deriving from kidney, lung, or melanoma (8, 12, 13, 21, 38) . Colony formation in already transformed cell lines is due to altered cellcell adhesion and anchorage independence, partly reflects the process of tumor progression, and differs greatly from the transformation of unaltered and mortal primary cells. Our data add to the profile of NORE1B and RASSF1A, indicating that these genes interfere with processes already at the very beginning of carcinogenesis.
Putative interaction partners of NORE1B. Harboring a RAdomain like NORE1A, NORE1B has been anticipated to bind GTPcharged Ras (20) . However, after cotransfection of NORE1Bwt and mutant Ha-Ras, there was no evidence for any interaction. Furthermore, NORE1B affected the cell cycle in Hep3B cells harboring wt-forms of Ha-, Ki-, and N-Ras and in MIMhepatocytes without or with activated Ras. Thus, NORE1B seems to act independently of Ras and loss of NORE1B function may render a growth advantage to hepatocytes with or without Ras mutation. NORE1B lacks the NH 2 -terminal DAG-domain, the putative RASSF1A binding site, and nevertheless interacts with this gene via the RA-and SARAH-domain. Cotransfections of RASSF1A with NORE1B-constructs containing the critical domains produced significant FRET-signals. Generally, efficient energy transfer of >50% through the resonant coupling of the dipole moments of the donor (CFP-tagged NORE1B) and acceptor (YFP-tagged RASSF1A) requires parallel orientation and proximity of <7 nm of the two fluorophores, and an interaction time beyond random molecular collisions (35) . Thus, FRET proves the molecular proximity between the two macromolecules, NORE1B and RASSF1A, and strongly suggests close physical interaction of the two peptides. Furthermore, FRET analyses are superior to conventional biochemical binding studies in that they allow to study living cells (35) .
Via heterodimerization NORE1B seems to be recruited to the microtubular binding sites of RASSF1A, as the colocalizing gene products seem to arrange as fibers. The molecular mechanisms of growth arrest by RASSF1A largely involve interactions with microtubules, as outlined above. Similar mechanisms may underlie the growth suppressing effects of NORE1B. Furthermore, as essential components of cell adhesion, intercellular contacts, and/or the cytoskeleton microtubuli affect cell morphology (39) . Accordingly, by binding to the microtubuli, NORE1B may induce the observed shift from fibroblastoid to an epitheloid, cobblestonelike morphology in the embryonal cells.
Lack of NORE1A silencing and hepatocarcinogenesis. As part of a multiprotein complex RASSF1A controls the cell cycle and recruits protein kinases to induce apoptosis (9, 10, (17) (18) (19) (27) (28) (29) (30) (31) (32) (33) . Our data show that RASSF1A heterodimerizes with both, NORE1A and NORE1B, but that only NORE1A seems to serve as link to GTPcharged Ras. Thus, it may be a critical point for a cell whether the RASSF1A-containing protein complex attaches to NORE1A or NORE1B and thus may be linked to active Ras or not. In human HCC NORE1B and RASSF1A are epigenetically silenced but not NORE1A (6) . Impaired function of NORE1A by mutations of the gene has already been excluded (6) . Because most of the HCCs lack Ras mutations, the adaptor function of NORE1A between RASSF1A and GTP-charged Ras-proteins may be of minor importance for hepatocytes to abrogate harmful Ras effects. This may explain that NORE1A is not frequently epigenetically silenced in the HCCs.
In conclusion, our data suggest that NORE1B and RASSF1A interact closely to antagonize cell transformation and to control Figure 5 . Confocal laser scanning microscopy of subcellular localization of NORE1Bwt, NORE1B deletion mutants, NORE1Awt, and RASSF1Awt. Hep3B cells were transiently transfected with pEYFP-tagged plasmids (green ) and cultured for 24 h with leptomycin B (solved in ethanol; applied at 10 ng/mL medium; Sigma) or solvent. Cells were fixed and counterstained with Hoechst 33258 (blue ). Images were obtained by LSM510Meta confocal microscope (Carl Zeiss) using a Â63 oil objective.
growth of hepatocytes. Thus, functional integrity of both genes seems to be fundamental in preventing the development of liver cancer.
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